NEO Stock Analysis: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$15.29
-0.59 (-3.72%)
▼
5d:
+10.08%
30d:
+2.14%
90d:
+65.12%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NEO is fairly valued with market pricing in 3.0% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: NEO is fairly valued with market pricing in 3.0% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $15.29, which is considered extended relative to its 30-day fair value range of $13.18 to $15.18. The stock's valuation (Forward PE: 45.2) is in line with its historical norms (41.4). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NEO is in a strong uptrend. Immediate support is located at $13.05, while resistance sits at $16.17. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.72 (+29.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NEO is in a strong uptrend. Immediate support is located at $13.05, while resistance sits at $16.17. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.72 (+29.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.18 -
$15.18
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
Protect Your Profits
Holding NEO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 29.0% below Wall St target ($19.72)
- NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$13.18 -
$15.18
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.05
Resistance Level
$16.17
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
45.21
Wall Street Target
$19.72
(+29.0%)
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
130.6%
Profit Margin
-6.8%
Valuation Premium vs History
+3.0% premium
PE vs Historical
45.2 vs 41.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$15.75
(+3%)
2-Year Target
$16.22
(+6%)
3-Year Target
$16.71
(+9%)
3-Yr Target (if PE normalizes)
(PE: 45→41)
PE COMPRESSION
$15.30
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 45.2, Growth: 85.1%)
$51.60
(+238%)
Base:
(SPY PE: 20.7, Growth: 85.1%)
$23.66
(+55%)
Bear:
(PE: 17.6, Growth: 85.1%)
$20.11
(+32%)
Share & Embed Analysis
Last updated: August 02, 2026 3:39 PM ET
Data refreshes hourly during market hours. Next update: 4:39 PM
Data refreshes hourly during market hours. Next update: 4:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced NEO Option Strategies
Professional options setups generated by AI based on today's NEO price and gamma walls.
